Distinguishing between Rigor and Transparency in FDA Marketing Authorization of AI-enabled Medical Devices
Radiology: Artificial Intelligence · 01.11.2025 · 7 (6)
DOI: 10.1148/ryai.250369 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Radiology: Artificial Intelligence, erschienen am 01.11.2025. Verfasst von Abdul Rahman Diab und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Data Science, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215. Hauptthemen laut MEDLINE: Artificial Intelligence, Device Approval, Radiology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Performance validation rigor and transparency are distinct yet often conflated aspects of U.S. Food and Drug Administration marketing authorization. Authors summarize the current state of each for radiology AI devices and offer recommendations that balance innovation, risk, and public trust.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Data Science, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.
- Department of Pathology, Brigham and Women's Hospital, Boston, Mass.
- Harvard Medical School, Boston, Mass.
ORCID-Profile: Abdul Rahman Diab, William Lotter
Zitieren
APA
Diab, A. R., & Lotter, W. (2025). Distinguishing between Rigor and Transparency in FDA Marketing Authorization of AI-enabled Medical Devices. Radiology: Artificial Intelligence, 7(6). https://doi.org/10.1148/ryai.250369
Vancouver
Diab AR, Lotter W. Distinguishing between Rigor and Transparency in FDA Marketing Authorization of AI-enabled Medical Devices. Radiology: Artificial Intelligence. 2025;7(6). doi:10.1148/ryai.250369
BibTeX
@article{Diab2025,
author = {Diab, Abdul Rahman and Lotter, William},
title = {Distinguishing between Rigor and Transparency in FDA Marketing Authorization of AI-enabled Medical Devices},
journal = {Radiology: Artificial Intelligence},
year = {2025},
volume = {7},
number = {6},
doi = {10.1148/ryai.250369}
}
EUVIMED